Catalyst Wire Dossier Catalyst Wire Dossier

CP-461

· Astellas Pharma Inc.
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for CP-461, covering 2011-10-17 to 2011-10-17. Get the full timeline:

Most recent: Clinical Trial Update: Study Using CP-461 to Treat Advanced Prostate Cancer [Phase 2]

See pricing